SCHEMBL5576869

SCHEMBL5576869

O=c1[nH]cccc1-c1cc2ccccc2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.54
MAOA P21397 1/20 0.54
PTPRC P08575 1/20 0.50
PTPN1 P18031 1/20 0.50
ADRA2A P08913 1/20 0.49
BRD4 O60885 2/20 0.47
CREBBP Q92793 2/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
IKBKB O14920 1/20 0.45
CHUK O15111 1/20 0.45
SIRT1 Q96EB6 1/20 0.44
RAB9A P51151 3/20 0.43
POLB P06746 2/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A1 P04798 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12854020 0.77 MAOB (0.71) MAOBMAOAPTPRCPTPN1ADRA2A
SCHEMBL61411 0.77 MAOB (0.71) MAOBMAOAPTPRCPTPN1ADRA2A
SCHEMBL17843529 0.76 NPC1 (0.56) MAOBMAOAPTPRCPTPN1ADRA2A
SCHEMBL7089566 0.74 MAOB (0.54) MAOBMAOAPTPRCPTPN1ADRA2A
SCHEMBL30417366 0.74 RAB9A (0.68) MAOBMAOAPTPRCPTPN1KMT2A
SCHEMBL6590629 0.72 MAOB (0.56) MAOBMAOAPTPRCPTPN1BRD4
SCHEMBL8764553 0.72 HPGD (0.54) MAOBMAOAPTPRCPTPN1KMT2A
SCHEMBL30036439 0.72 MAOB (0.63) MAOBMAOAPTPRCPTPN1ADRA2A
SCHEMBL103158 0.72 MAOB (0.63) MAOBMAOAPTPRCPTPN1ADRA2A
SCHEMBL3048109 0.72 MAOB (0.51) MAOBMAOAPTPRCPTPN1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060606-A1 Compounds and methods for modulating phosphodiesterase 10A DALHOUSIE UNIVERSITY (CA) 2007-03-15 US disclosed
JP-2000128878-A BENZOFURYL-ALPHA-PYRIDONE DERIVATIVE TEIJIN LTD 2000-05-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060606-A1 Compounds and methods for modulating phosphodiesterase 10A PDE7A, PDE10A, PDE2A MAOB 111/4885MAOA 145/4885PTPRC 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.